An Arnold & Porter attorney for Endo Pharmaceuticals said that a lawyer for New York made "false and misleading" accusations to the judge overseeing the state's opioid trial that the company didn't inform the state of a failed federal inspection of a facility operated by its unit Par Pharmaceutical Inc.